About MBX Capital
MBX Capital is a venture capital firm founded in 2015. It is primarily based out of New York City, United States. As of Apr 2026, MBX Capital is an active investor, having invested in 72 companies, with 2 new investments in the last 12 months. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to HealthTech and Enterprise Applications. Most recently it participated in the $***** Series A round of Keebler Overall, MBX Capital portfolio has seen 1 unicorn, 2 IPOs and 5 acquisitions including key companies like Osmosis, Opentrons and CareRev. A lot of funds co-invest with MBX Capital, with names like Alpha Wave Global sharing a substantial percentage of its portfolio. MBX Capital has team of 18 people including 4 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Seed & 1 more
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns
MBX Capital's List of Top Investments
MBX Capital has a portfolio of 72 companies, one of which is a Unicorn. Their most notable investments are in Contraline and Freedom Bio.Their portfolio spans across United States, Canada, India and 2 more locations. They have invested in Life Sciences, HealthTech, Enterprise Applications and 11 other sectors, across stages such as Series A, Seed and 1 more. Here is the list of top investments by MBX Capital:1. Osmosis
Educational resources platform for medical students and professionals. Allows students to upload curricular material, such as documents and lectures, create their own flashcards, questions, and answer these assessment items using spaced repetition. Scoreboard shows a student their accuracy, confidence, and retention of knowledge, while the platform recommends additional resources such as videos and articles.
Key facts about Osmosis
- Founded Year: 2012
- Location: Charlottesville (United States)
- Stage: Acquired
- Total Funding till date: $8.99M
- Employee Count: 336 as on Sep 30, 2026
- Investors: Felicis Ventures, Education Competition and 23 Others
- Latest Funding Round: Series A, Nov 07, 2023, $*****
- Highlight: Acquired
On-demand nonemergency transport platform to healthcare organizations. The company's mobile app brings new business to non-emergency medical drivers who want to pick up on-demand rides. It responds to ride requests much like an Uber or Lyft experience. The company solutions also include tools to engage the patient (increasing adherence) and analytics to identify and triage "at risk" patients.
Key facts about Safe Ride Health
- Founded Year: 2015
- Location: Los Angeles (United States)
- Stage: Series C
- Total Funding till date: $39M
- Employee Count: 310 as on Sep 30, 2026
- Investors: Sands Capital, SVB and 20 Others
- Latest Funding Round: Series C, Oct 06, 2023, $*****
- Highlight: Editors' Pick
3. Fathom
Provider of autonomous medical coding platform and related coding services. The company offers production coding, backlog processing, and real-time audit functionalities. The platform automates medical coding, aiming to reduce costs and improve accuracy. It provides coding capacity and helps to review coding work.
Key facts about Fathom
- Founded Year: 2017
- Location: San Francisco (United States)
- Valuation: $*****
- Stage: Series B
- Total Funding till date: $61M
- Employee Count: 72 as on Sep 30, 2026
- Investors: Alkeon Capital Management, XG Ventures and 15 Others
- Latest Funding Round: Series B, May 04, 2026, $*****
- Highlight: Editors' Pick
Provider of a neurological disease diagnostic tool for providers. The company has developed a diagnostic kit called Syn-One Test which assists in the diagnosis of synucleinopathy in patients. The kit is a skin biopsy tool that has the ability to detect and visualize abnormal skin cell conditions based on pathological evidence.
Key facts about CND Life Sciences
- Founded Year: 2017
- Location: Phoenix (United States)
- Stage: Series A
- Total Funding till date: $28.9M
- Employee Count: 150 as on Aug 31, 2026
- Investors: Top Corner Capital, LabCorp and 14 Others
- Latest Funding Round: Series A, Aug 04, 2026, $*****
- Highlight: Editors' Pick
5. Rula
Online platform offering mental health therapy services. The platform enables users to browse through profiles of mental health professionals to match with preferences and schedule appointment for virtual consultation sessions.
Key facts about Rula
- Founded Year: 2019
- Location: Los Angeles (United States)
- Stage: Series A
- Total Funding till date: $5.3M
- Employee Count: 326 as on Sep 30, 2026
- Investors: Harmony Partners, Icon Ventures and 7 Others
- Latest Funding Round: Series A, Oct 30, 2019, $*****
MBX Capital's Year-on-Year Investment Trends
MBX Capital has invested in 72 companies over the last 6 years, with an average of 4 new investments annually in the last 5 years. In 2025, it made 5 investments, while as of Apr 2026, it has made 3 investments in this year. Its most recent first time investment was in Dognosis and most recent follow-on round was in Keebler.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 2 | 1 | 3 |
2025 | 4 | 1 | 5 |
2024 | 0 | 0 | 0 |
2023 | 3 | 0 | 3 |
2022 | 8 | 2 | 10 |
2021 | 5 | 0 | 5 |
2020 | 1 | 0 | 1 |
MBX Capital's Investments by Stage
MBX Capital has made 13 investments in Series A stage with an average round size of $23.3M, 7 investments in Seed stage with an average round size of $9.87M and 3 investments in Series B stage with an average round size of $61.7M.Stage of entry | No. of Investments |
|---|---|
Series A | 13 |
Seed | 7 |
Series B | 3 |
Note: We have considered here, only first round of investments
MBX Capital's Investments by Sector
MBX Capital has a diverse portfolio, with companies operating in the HealthTech, Enterprise Applications, Life Sciences, Healthcare and Vertical SaaS. Notably, it has invested in 58 Tech companies, 47 Enterprise (B2B) companies, 28 Software companies and at least 19 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
HealthTech | 9 |
Enterprise Applications | 7 |
Life Sciences | 7 |
Healthcare | 6 |
Vertical SaaS | 4 |
Others | 9 |
Note: We have considered here, only first round of investments
MBX Capital's Investments by Geography
MBX Capital has made most investments in United States (18), followed by India where it has made 3 investments.Country | No. of Investments |
|---|---|
United States | 18 |
India | 3 |
Canada | 1 |
Mexico | 1 |
Note: We have considered here, only first round of investments
MBX Capital's recent investments
MBX Capital has made 3 investments in 2026 so far. Keebler and Dognosis are the latest among them.Here are the most recent investments by MBX Capital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Apr 15, 2026 | United States | Series A | 4186 | ||
Mar 25, 2026 | India | Seed | 4285 | [+4] | |
Jan 20, 2026 | United States | Series A | 6497 | [+7] | |
May 29, 2025 | United States | Series A | 7461 | [+6] | |
May 19, 2025 | United States | Series A | 1329 | [+11] |
Unicorns in MBX Capital's Portfolio
MBX Capital has 1 unicorn in its portfolio - Opentrons. The most recent unicorn in their portfolio is Opentrons which became a unicorn in 2021, 5 years before MBX Capital first invested in it.Here is a list of unicorns in MBX Capital's portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
61 | Developer of pipetting robot for lab automation | 2013 | Brooklyn | Series C | pdzjttr |
IPOs and Publicly Listed companies in MBX Capital's Portfolio
2 of MBX Capital's portfolio companies have become public. Vaxxinity got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Nov 2021 at marketcap of $1.62B and NeuroOne got listed on the OTC Markets (OTCMKTS) at marketcap of undefined.Here are MBX Capital's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Nov 11, 2021 | - | - | 8508 | |
Aug 04, 2017 | - | - | 6219 |
Acquired companies in MBX Capital's Portfolio
5 companies from MBX Capital's portfolio have been acquired. The most recent acquisition was OFFOR Health in Apr 2026 by Havencrest Capital Management for $*****.Here are MBX Capital's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Apr 09, 2026 | Apr 26, 2022 | Series A | 1833 | |
Jan 08, 2026 | - | - | 6225 | |
Sep 18, 2024 | - | - | 3923 | |
Aug 04, 2022 | - | - | 5696 | |
Nov 29, 2021 | - | - | 3481 |
_1551172230644.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Team profile of MBX Capital
MBX Capital has a team of 18 members including 4 Partners and 4 Venture Partners located in United States. MBX Capital's team does not sit on the board of any company as of now.Here is a list of top team members in MBX Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Washington, DC | - | ||
Partner | New York City | - | ||
Partner | San Francisco | - | - | |
Partner | New York | - | - | |
Venture Partner | San Diego | - | - | |
Venture Partner | New York City | - | - | |
Venture Partner | New York City | - | - | |
Venture Partner | Washington, DC | - | - |
Co-investors of MBX Capital
Over the past 6 years, 218 investors have co-invested in MBX Capital's portfolio companies. This includes funds and angels.
- Invested before MBX Capital: 100X.VC, Peak XV Partners and 60 others have invested in rounds before MBX Capital. There are 3 companies where 100X.VC has invested before MBX Capital and 3 companies where Peak XV Partners has invested before MBX Capital.
- Top Co-investors of MBX Capital: 110 investors entered a company along with MBX Capital. These include investors like Alpha Wave Global (3 companies).
- Invested after MBX Capital: A total of 46 investors have invested in MBX Capital's portfolio after their investments. Top Investors include Spring (2 companies), Accenture (1 company) and Biospring Partners (1 company).
Recent News related to MBX Capital
•
Keebler Health Raises $16M in Series A FundingFinSMEs•Apr 15, 2026•Keebler, Flare Capital Partners, Sands Capital, keeblerhealth.com and 9 others
•
Think Bioscience Raises $55M in Oversubscribed Series Aintelligence360•Feb 09, 2026•Regeneron Ventures, Think Bioscience, Buff Gold Ventures, CE Venture Capital and 4 others
•
Think Bioscience Raises $55M in Series A FundingFinSMEs•Jan 20, 2026•Regeneron Ventures, Think Bioscience, Buff Gold Ventures, CE Venture Capital and 5 others
•
Persist AI Launches Cloud Lab to Accelerate Pharmaceutical Formulation Development, Raises $12M Series A Fundingintelligence360•Jun 02, 2025•PERSIST.AI, Spero Ventures, MBX Capital, Shimadzu and 9 others
•
Vivodyne Secures $40M in Series A Funding to Advance Drug Testing TechnologyFinSMEs•May 29, 2025•Vivodyne, Khosla Ventures, Lingotto, Helena Capital and 5 others
•
Persist AI Launches Cloud Lab to Accelerate Pharmaceutical Formulation Development, Raises $12M Series A FundingPR Newswire•May 19, 2025•PERSIST.AI, Spero Ventures, MBX Capital, Global Brain and 10 others
•
CND Life Sciences Closes $13.5M Series A FundingFinSMEs•May 01, 2025•CND Life Sciences, cambriancapital.ca, Tanis Ventures, Top Corner Capital and 5 others
•
Keebler Health Raises $6M to Automate Risk Adjustment for Healthcare Providers in Value-Based Care EnvironmentsBenzinga•Feb 18, 2025•Keebler, Freestyle, MBX Capital, New Stack Ventures and 8 others
•
Tidal Vision Raises $140M Series B FundingFinSMEs•Feb 06, 2025•Tidal Vision, Eni Next, Milliken, KIRKBI A/S and 5 others
•
Tidal Vision, a company turning tossed crab shells into a green chemical, nets $140M in fundingGeekWire•Feb 03, 2025•Tidal Vision, Cambridge Companies SPG, Eni Next, Milliken and 5 others
